+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Active Pharmaceutical Ingredients (API) Global Market - Forecast to 2025

  • ID: 4769388
  • Report
  • Region: Global
  • 625 Pages
  • IQ4I Research & Consultancy Pvt. Ltd
1 of 5

FEATURED COMPANIES

  • Aarti Drugs Ltd
  • Astrazeneca Plc.
  • Dcs Pharma AG
  • Indena
  • Neuland Laboratories Ltd.
  • Saamya Biotech
  • MORE

Active Pharmaceutical Ingredients (APIs) are active substances in a drug intended to achieve pharmacological activity which is having a direct effect on disease treatment. APIs are synthesized by chemical synthesis, fermentation, biotechnological methods or enhanced from natural source. According to the author's analysis, the global Active Pharmaceutical Ingredient market is expected to grow at a high CAGR to reach $307.2 billion by 2025. Adoption of biologics in disease management and increasing regulatory approvals in the past year, increasing scope of HPAPI market, patent expiration of major drugs, increasing trend of outsourcing and increase in geriatric population are some of the factors driving the market growth. The global API market is mainly segmented by synthesis, by business type, by application and by geography.

API market based on synthesis is further divided into synthetic API, Biotech API, and HPAPI. Synthetic API holds a major share in 2018 and is expected to grow at a mid-single digit CAGR from 2018 to 2025. The major factors driving the synthetic chemical API market are patent expiration of synthetic (small molecule drugs), increasing number of small molecules in clinical trials, increasing outsourcing by the pharmaceutical companies, CMOs investments to expand manufacturing facilities, rise in incidence of chronic and age-related diseases, rapid growth in oncology market, technological advancement like cryogenic and continuous flow manufacturing. Based on the customer, the synthetic API is further divided into branded API and generic API. Branded API accounted for the largest share in 2018 and is expected to grow at a mid-single digit CAGR from 2018 to 2025. Generic API is expected to grow at a high single-digit CAGR from 2018 to 2025, due to Patent expiry of blockbuster drugs, rising healthcare expenses, increasing outsourcing and shift towards the generic medicines led by the government initiatives.

Biotech API is expected to grow at a high single-digit CAGR from 2018 to 2025. Increased investment in R&D by pharmaceutical companies for developing biologic drugs, adoption of biological therapies in disease management, increasing outsourcing, increasing biologics approvals in the past year, increasing chronic and autoimmune illnesses, increasing number of branded drugs going off-patent creating a scope for biosimilars, requirement of novel biologics therapeutics for rare diseases, increasing demand for antibody conjugates are few factors driving the biotech API market. Biotech API is further segmented into monoclonal antibodies, recombinant proteins, vaccines and others (stem cell therapy and gene therapy). Monoclonal antibodies accounted for the highest share in 2018 and expected to grow at a double-digit CAGR from 2018 to 2025. Development of next-generation antibodies such as antibody-drug conjugates and rising venture capital investments and applications of monoclonal antibodies are the factors booming monoclonal antibodies market growth. Based on the customer, biotech API is further divided into biologics and biosimilars. Biologics accounted for the largest share in 2018 and is expected to grow at a high single-digit CAGR from 2018 to 2025. Biologics market is driven globally due to the adoption of biological therapies in disease management, increasing biologics approvals in the past year, increasing chronic and autoimmune illnesses and increasing elderly population globally. Biosimilars are expected to grow at a mid-double-digit CAGR from 2018 to 2025. Factors driving the biosimilar drug market are patent expiry of biological drugs, low cost compared to biologics health care expenditure, increase in chronic diseases, growing geriatric population, demand for quality healthcare.

HPAPI is expected to grow at a high single-digit CAGR from 2018 to 2025. Rapid growth in the oncology market, low toxicity and lower side effects, technological advancements in HPAPI, increasing outsourcing, increasing the incidence of chronic and age-related diseases are few factors driving the HPAPI market growth. Based on customer, HPAPI is further divided into branded API and generic API. Branded API is accounted the largest share in 2018 and is expected to grow at a high single-digit CAGR from 2018 to 2025, increased development of targeted therapy APIs, increased investments in the manufacturing of branded HPAPI are the factors driving the market. Generic API is expected to grow at a high single-digit CAGR from 2018 to 2025. Patent expiry of blockbuster drugs, rising healthcare expenses and shift towards the generic medicines led by the government initiatives are some of the factors driving the generic HPAPI market.

By business type, the global API market is divided into captive API and merchant API. Captive market holds major share in 2018 and is expected to grow at a mid-single digit CAGR from 2018 to 2025, captive API is further divided into branded captive API and generic captive API, branded captive API accounted for the largest share in 2018 and is expected to grow at a mid-single- digit CAGR from 2018 to 2025. Merchant API market is the fastest growing segment with a high single-digit CAGR from 2018 to 2025. Novel drugs patent expiry, high cost of innovative drugs and complications in innovative drug manufacturing are some of the factors driving the growth of the Merchant API market. Merchant API market is further divided into branded merchant API and generic merchant API. Generic merchant API accounted for the largest share in 2018 and is expected to grow at a double-digit CAGR from 2018 to 2025. Increasing outsourcing, advanced manufacturing facilities, lack of in-house manufacturing capability, high capital investment and cost of API manufacturing are the factors driving the Merchant API market.

By therapeutic applications, API market is segmented into infectious diseases, oncology, cardiovascular disorders, central nervous system, a pulmonary disorder, gastrointestinal disorder, endocrine disorders, metabolic disorders, genito-urinary disorders, musculoskeletal disorders and others. In the application segment, Oncology holds a major share in 2018 and expected to grow at a high single-digit CAGR from 2018 to 2025. In synthetic API, infectious diseases accounted the largest share in 2018 and is expected to grow at a high single-digit CAGR from 2018 to 2025, oncology is expected to grow at a high single-digit CAGR from 2018 to 2025. In biotech API, musculoskeletal disorders accounted the largest share in 2018 and the share is expected to grow at a high single-digit CAGR from 2018 to 2025, oncology is expected to grow at a double-digit CAGR from 2018 to 2025. In HPAPI, oncology accounted for the largest share in 2018 and is expected to grow at a high single-digit CAGR from 2018 to 2025. Biotech API and HPAPI is driving the market growth at a faster pace due to rising targeted therapy demand in the last 15 years for the treatment of diseases, mainly in the oncology sector.

Active pharmaceutical Ingredients market by region is segmented as North America, Europe, Asia-Pacific and Rest of the world (ROW) where North America holds the largest share in 2018 and is expected to grow at a high single-digit CAGR from 2018 to 2025. Patent expiration of the major drugs, rising demand for biotech APIs from government and private companies, market entry of biosimilars, increasing the scope of highly potent drugs and increase in the prevalence of chronic diseases such as cancer, musculoskeletal disorder, cardiac disease are some of the major factors driving the North America API market. Asia-Pacific region is expected to grow at a high single-digit CAGR from 2018 to 2025. Low labor cost, abundance availability of raw materials, infrastructure facility, rise in generic drugs demand, increased production capabilities, the presence of a large number of domestic and international players, and concentration of CMO companies are some of the factors that are driving the market growth.

Some of the key players of Active Pharmaceutical Ingredient (API) market are Lonza Group (Switzerland), Boehringer Ingelheim GmbH (Germany), Teva Pharmaceutical Industries LTD (Israel), Sanofi (France), Patheon N.V (U.S), Aurobindo pharmaceuticals. (India), Seigfried Holdings A.G (Switzerland), Olon S.p.A (Italy), Pfizer Inc. (U.S.), GlaxoSmithKline plc. (U.K.), Cambrex Corporation (U.S.) and AMRI, (U.S.).

The report provides an in-depth market analysis of the above-mentioned segments across the following regions:

North America

  • The U.S.
  • Rest of North America

Europe

  • Italy
  • Germany
  • France
  • Rest of Europe

Asia-Pacific

  • China
  • Japan
  • India
  • Rest of APAC

Rest of the World (RoW)

  • Brazil
  • Rest of Latin America
  • Middle East and Others
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Aarti Drugs Ltd
  • Astrazeneca Plc.
  • Dcs Pharma AG
  • Indena
  • Neuland Laboratories Ltd.
  • Saamya Biotech
  • MORE

1 Executive Summary

2 Introduction
2.1 Key Takeaways
2.2 Scope Of The Report
2.3 Report Description
2.4 Markets Covered
2.5 Stakeholders
2.6 Research Methodology
2.6.1 Market Size Estimation
2.6.2 Market Breakdown And Data Triangulation
2.6.3 Secondary Sources
2.6.4 Primary Sources
2.6.5 Key Data Points From Secondary Sources
2.6.6 Key Data Points From Primary Sources
2.6.7 Assumptions

3 Market Analysis
3.1 Introduction
3.2 Market Segmentation
3.3 Factors Influencing Market
3.3.1 Drivers And Opportunities
3.3.1.1 Adoption Of Biologics In Disease Management And Increasing Regulatory Approvals In The Past Year
3.3.1.2 Increasing Scope Of Hpapi Market
3.3.1.3 Patent Expiration Of Major Drugs
3.3.1.4 Increasing Trend Of Outsourcing
3.3.1.5 Increase In Geriatric Population
3.3.2 Restraints And Threats
3.3.2.1 Contamination Of API
3.3.2.2 Fierce Competition Between API Players
3.3.2.3 High Cost For Manufacturing APIs
3.3.2.4 Requirement Of Highly Skilled Technicians
3.3.2.5 Stringent Regulatory Policies And Environmental Concerns
3.4 Regulatory Affairs
3.4.1 International Organization For Standardization
3.4.1.1 ISO 9001: 2015 Quality Management System
3.4.1.2 ISO 13408 Aseptic Processing
3.4.1.3 ISO 14644-1 Clean Room Standards
3.4.2 U.S.
3.4.3 Canada
3.4.4 Mexico
3.4.5 Europe
3.4.6 China
3.4.7 India
3.4.8 Japan
3.4.9 Australia
3.4.10 South Korea
3.4.11 Latin America
3.4.12 Middle East
3.5 Technological Advancements
3.5.1 Introduction
3.5.2 Automation And Control
3.5.3 Continuous Manufacturing
3.5.4 Cryogenic Technology
3.5.5 Single - Use System (SUS)
3.5.6 Mammalian Cell Based Production
3.6 Porter's Five Force Analysis
3.6.1 Threat Of New Entrants
3.6.2 Threat Of Substitutes
3.6.3 Bargaining Power Of Suppliers
3.6.4 Bargaining Power Of Buyers
3.6.5 Competitive Rivalry
3.7 Supply Chain Analysis
3.8 Market Share Analysis
3.9 API Manufacturing Units
3.10 Global Pharmaceutical API Production Volume
3.11 Patent Expiry And ANDA Approvals
3.12 Companies Acquisition, Merger And Expansions
3.13 Collaboration And Agreement Between API Manufacturers
3.14 Selected Top Selling API
3.15 API Manufacturers Revenue And Capabilities Table

4 API Global Market, By Synthesis
4.1 Introduction
4.2 Synthetic API
4.2.1 Synthetic API By Customer Base
4.2.1.1 Branded Synthetic API
4.2.1.2 Generic Synthetic API
4.3 Biotech API
4.3.1 Introduction
4.3.1.1 Monoclonal Antibodies
4.3.1.2 Recombinant Proteins
4.3.1.3 Vaccines
4.3.1.4 Others
4.3.2 Biotech API By Customer Base
4.3.2.1 Biologic API
4.3.2.2 Biosimilar API
4.4 HPAPI
4.4.1 HPAPI By Customer Base
4.4.1.1 Branded HPAPI
4.4.1.2 Generic HPAPI

5 API Global Market, By Business Type
5.1 Introduction
5.2 Captive API By Type
5.2.1 Branded Captive API
5.2.2 Generic Captive API
5.3 Merchant API By Type
5.3.1 Branded Merchant API
5.3.2 Generic Merchant API

6 API Global Market, By Application
6.1 Introduction
6.2 Infectious Diseases
6.3 Oncology
6.4 Cardiovascular Disorders
6.5 Central Nervous System
6.6 Pulmonary Disorders
6.7 Gastrointestinal Disorders
6.8 Endocrine Disorders
6.9 Metabolic Disorders
6.10 Genitourinary Disorders
6.11 Musculoskeletal Disorders
6.12 Other Applications

7 Regional Analysis
7.1 Introduction
7.2 North America
7.2.1 U.S.
7.2.2 Rest Of North America
7.3 Europe
7.3.1 Italy
7.3.2 Germany
7.3.3 France
7.3.4 Rest Of Europe
7.4 APAC
7.4.1 China
7.4.2 Japan
7.4.3 India
7.4.4 Rest Of APAC
7.5 RoW
7.5.1 Brazil
7.5.2 Rest Of LATAM
7.5.3 Middle East & Others

8 Competitive Landscape
8.1 Introduction
8.2 Expansions
8.3 Approvals
8.4 Acquisitions
8.5 Agreements And Collaboration
8.6 Others

9 Major Companies
9.1 Albany Molecular Research Inc.
9.1.1 Overview
9.1.2 Financials
9.1.3 Product Portfolio
9.1.4 Key Developments
9.1.5 Business Strategy
9.1.6 SWOT Analysis
9.2 Aurobindo Pharma Limited
9.2.1 Overview
9.2.2 Financials
9.2.3 Product Portfolio
9.2.4 Key Developments
9.2.5 Business Strategy
9.2.6 SWOT Analysis
9.3 Boehringer Ingelheim GmbH
9.3.1 Overview
9.3.2 Financials
9.3.3 Product Portfolio
9.3.4 Key Developments
9.3.5 Business Strategy
9.3.6 SWOT Analysis
9.4 Cambrex Corporation
9.4.1 Overview
9.4.2 Financials
9.4.3 Product Portfolio
9.4.4 Key Developments
9.4.5 Business Strategy
9.4.6 SWOT Analysis
9.5 Divis Laboratories
9.5.1 Overview
9.5.2 Financials
9.5.3 Product Portfolio
9.5.4 Key Developments
9.5.5 Business Strategy
9.5.6 SWOT Analysis
9.6 GlaxoSmithKline plc
9.6.1 Overview
9.6.2 Financials
9.6.3 Product Portfolio
9.6.4 Key Developments
9.6.5 Business Strategy
9.6.6 SWOT Analysis
9.7 Lonza Group Ltd.
9.7.1 Overview
9.7.2 Financials
9.7.3 Product Portfolio
9.7.4 Key Developments
9.7.5 Business Strategy
9.7.6 SWOT Analysis
9.8 Olon S.P.A.
9.8.1 Overview
9.8.2 Financials
9.8.3 Product Portfolio
9.8.4 Key Developments
9.8.5 Business Strategy
9.8.6 SWOT Analysis
9.9 Thermo Fisher Scientific (Patheon N.V.)
9.9.1 Overview
9.9.2 Financials
9.9.3 Product Portfolio
9.9.4 Key Developments
9.9.5 Business Strategy
9.9.6 SWOT Analysis
9.10 Pfizer Inc.
9.10.1 Overview
9.10.2 Financials
9.10.3 Product Portfolio
9.10.4 Key Developments
9.10.5 Business Strategy
9.10.6 SWOT Analysis
9.11 Sanofi
9.11.1 Overview
9.11.2 Financials
9.11.3 Product Portfolio
9.11.4 Key Developments
9.11.5 Business Strategy
9.11.6 SWOT Analysis
9.12 Siegfried Holding AG
9.12.1 Overview
9.12.2 Financials
9.12.3 Product Portfolio
9.12.4 Key Developments
9.12.5 Business Strategy
9.12.6 SWOT Analysis
9.13 Teva Pharmaceuticals Industries Limited
9.13.1 Overview
9.13.2 Financials
9.13.3 Product Portfolio
9.13.4 Key Developments
9.13.5 Business Strategy
9.13.6 SWOT Analysis

List of Tables
Table 1 API Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 2 Global Small Molecule API Revenue ($Mn), Average Selling Price ($/Kg) And Production In Tons, By Application (2018)
Table 3 Global Small Molecule Volume And Utilization, CMO Volume And Utilization, (2017-2025) (Million Litres)
Table 4 Global Small Molecule API Production, By Application, (2017-2025) (Tons)
Table 5 Global Biologics Volume And Utilization, CMO Volume And Utilization, (2017-2025) (Million Litres)
Table 6 Global Small Molecule API Production, (2017-2025) (Metric Tons)
Table 7 Global Biologics API Production, (2017-2025) (Metric Tons)
Table 8 Global API Production, (2017-2025) (Metric Tons)
Table 9 Patent Expiry Of Synthetic API Drugs, (2016 – 2021)
Table 10 Patent Expiry Of Biotech API Drugs, (2017 – 2018)
Table 11 Anda Approvals: Small Molecules - Generics, (2017 – 2028)
Table 12 Anda Approvals: Biosimilars, (2016 – 2018)
Table 13 Companies Acquisition, Merger And Expansions, (2017 – 2019)
Table 14 Expansions, (2016 – 2018)
Table 15 Collaborations And Agreements, (2017 – 2018)
Table 16 API Global Market Revenue, By Synthesis, (2017-2025) ($Mn)
Table 17 API Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 18 Synthetic API Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 19 Synthetic API Global Market Revenue, By Customer Base, (2017-2025) ($Mn)
Table 20 Branded Synthetic API Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 21 Generic Synthetic API Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 22 Biotech API Global Market Revenue, By Product Type, (2017-2025) ($Mn)
Table 23 Biotech API Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 24 Monoclonal Antibodies Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 25 Recombinant Proteins Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 26 Vaccines Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 27 Other Biotech API Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 28 Biotech API Global Market Revenue, By Customer Base, (2017-2025) ($Mn)
Table 29 Biologic API Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 30 Biosimilar API Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 31 HPAPI Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 32 HPAPI Global Market Revenue, By Customer Base, (2017-2025) ($Mn)
Table 33 Branded HPAPI Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 34 Generic HPAPI Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 35 API Global Market Revenue, By Business Type, (2017-2025) ($Mn)
Table 36 Captive API Global Market Revenue, By Type, (2017-2025) ($Mn)
Table 37 Captive API Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 38 Branded Captive API Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 39 Generic Captive API Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 40 Merchant API Global Market Revenue, By Type, (2017-2025) ($Mn)
Table 41 Merchant API Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 42 Branded Merchant API Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 43 Generic Merchant API Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 44 API Global Market Revenue, By Application, (2017-2025) ($Mn)
Table 45 Synthetic API Global Market Revenue, By Application, (2017-2025) ($Mn)
Table 46 Biotech API Global Market Revenue, By Application, (2017-2025) ($Mn)
Table 47 HPAPI Global Market Revenue, By Application, (2017-2025) ($Mn)
Table 48 Infectious Diseases API Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 49 Synthetic Infectious Diseases API Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 50 Biotech Infectious Diseases API Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 51 HPAPI Infectious Diseases API Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 52 Oncology API Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 53 Synthetic Oncology API Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 54 Biotech Oncology API Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 55 HPAPI Oncology API Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 56 Cardiovascular Disorders API Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 57 Synthetic Cardiovascular Disorders API Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 58 Biotech Cardiovascular Disorders API Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 59 HPAPI Cardiovascular Disorders API Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 60 Central Nervous System API Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 61 Synthetic Central Nervous System API Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 62 Biotech Central Nervous System API Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 63 HPAPI Central Nervous System API Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 64 Pulmonary Disorders API Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 65 Synthetic Pulmonary Disorders API Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 66 Biotech Pulmonary Disorders API Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 67 HPAPI Pulmonary Disorders API Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 68 Gastrointestinal Disorders API Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 69 Synthetic Gastrointestinal Disorders API Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 70 Biotech Gastrointestinal Disorders API Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 71 HPAPI Gastrointestinal Disorders API Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 72 Endocrine Disorders API Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 73 Synthetic Endocrine Disorders API Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 74 Biotech Endocrine Disorders API Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 75 HPAPI Endocrine Disorders API Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 76 Metabolic Disorders API Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 77 Synthetic Metabolic Disorders API Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 78 Biotech Metabolic Disorders API Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 79 HPAPI Metabolic Disorders API Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 80 Genitourinary Disorders API Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 81 Synthetic Genitourinary Disorders API Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 82 Biotech Genitourinary Disorders API Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 83 HPAPI Genitourinary Disorders API Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 84 Musculoskeletal Disorders API Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 85 Synthetic Musculoskeletal Disorders API Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 86 Biotech Musculoskeletal Disorders API Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 87 HPAPI Musculoskeletal Disorders API Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 88 Other Applications API Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 89 Synthetic Other Applications API Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 90 Biotech Other Applications API Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 91 HPAPI Other Applications API Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 92 API Global Market Revenue, By Region, (2017-2025) ($Mn)
Table 93 North America API Market Revenue, By Synthesis, (2017-2025) ($Mn)
Table 94 North America Biotech API Market Revenue, By Type, (2017-2025) ($Mn)
Table 95 North America Synthetic API Market Revenue, By Customer Base, (2017-2025) ($Mn)
Table 96 North America Biotech API Market Revenue, By Customer Base, (2017-2025) ($Mn)
Table 97 North America HPAPI Market Revenue, By Customer Base, (2017-2025) ($Mn)
Table 98 North America API Market Revenue, By Business Type, (2017-2025) ($Mn)
Table 99 North America Captive API Market Revenue, By Type, (2017-2025) ($Mn)
Table 100 North America Merchant API Market Revenue, By Type, (2017-2025) ($Mn)
Table 101 North America API Market Revenue, By Application, (2017-2025) ($Mn)
Table 102 North America Synthetic API Market Revenue, By Application, (2017-2025) ($Mn)
Table 103 North America Biotech API Market Revenue, By Application, (2017-2025) ($Mn)
Table 104 North America HPAPI Market Revenue, By Application, (2017-2025) ($Mn)
Table 105 North America API Market Revenue, By Country, (2017-2025) ($Mn)
Table 106 Europe API Market Revenue, By Synthesis, (2017-2025) ($Mn)
Table 107 Europe Biotech API Market Revenue, By Type, (2017-2025) ($Mn)
Table 108 Europe Synthetic API Market Revenue, By Customer Base, (2017-2025) ($Mn)
Table 109 Europe Biotech API Market Revenue, By Customer Base, (2017-2025) ($Mn)
Table 110 Europe HPAPI Market Revenue, By Customer Base, (2017-2025) ($Mn)
Table 111 Europe API Market Revenue, By Business Type, (2017-2025) ($Mn)
Table 112 Europe Captive API Market Revenue, By Type, (2017-2025) ($Mn)
Table 113 Europe Merchant API Market Revenue, By Type, (2017-2025) ($Mn)
Table 114 Europe API Market Revenue, By Application, (2017-2025) ($Mn)
Table 115 Europe Synthetic API Market Revenue, By Application, (2017-2025) ($Mn)
Table 116 Europe Biotech API Market Revenue, By Application, (2017-2025) ($Mn)
Table 117 Europe HPAPI Market Revenue, By Application, (2017-2025) ($Mn)
Table 118 Europe API Market Revenue, By Country, (2017-2025) ($Mn)
Table 119 APAC API Market Revenue, By Synthesis, (2017-2025) ($Mn)
Table 120 APAC Biotech API Market Revenue, By Type, (2017-2025) ($Mn)
Table 121 APAC Synthetic API Market Revenue, By Customer Base, (2017-2025) ($Mn)
Table 122 APAC Biotech API Market Revenue, By Customer Base, (2017-2025) ($Mn)
Table 123 APAC HPAPI Market Revenue, By Customer Base, (2017-2025) ($Mn)
Table 124 APAC API Market Revenue, By Business Type, (2017-2025) ($Mn)
Table 125 APAC Captive API Market Revenue, By Type, (2017-2025) ($Mn)
Table 126 APAC Merchant API Market Revenue, By Type, (2017-2025) ($Mn)
Table 127 APAC API Market Revenue, By Application, (2017-2025) ($Mn)
Table 128 APAC Synthetic API Market Revenue, By Application, (2017-2025) ($Mn)
Table 129 APAC Biotech API Market Revenue, By Application, (2017-2025) ($Mn)
Table 130 APAC HPAPI Market Revenue, By Application, (2017-2025) ($Mn)
Table 131 APAC API Market Revenue, By Country, (2017-2025) ($Mn)
Table 132 RoW API Market Revenue, By Synthesis, (2017-2025) ($Mn)
Table 133 RoW Biotech API Market Revenue, By Type, (2017-2025) ($Mn)
Table 134 RoW Synthetic API Market Revenue, By Customer Base, (2017-2025) ($Mn)
Table 135 RoW Biotech API Market Revenue, By Customer Base, (2017-2025) ($Mn)
Table 136 RoW HPAPI Market Revenue, By Customer Base, (2017-2025) ($Mn)
Table 137 RoW API Market Revenue, By Business Type, (2017-2025) ($Mn)
Table 138 RoW Captive API Market Revenue, By Type, (2017-2025) ($Mn)
Table 139 RoW Merchant API Market Revenue, By Type, (2017-2025) ($Mn)
Table 140 RoW API Market Revenue, By Application, (2017-2025) ($Mn)
Table 141 RoW Synthetic API Market Revenue, By Application, (2017-2025) ($Mn)
Table 142 RoW Biotech API Market Revenue, By Application, (2017-2025) ($Mn)
Table 143 RoW HPAPI Market Revenue, By Application, (2017-2025) ($Mn)
Table 144 RoW API Market Revenue, By Country, (2017-2025) ($Mn)
Table 145 Expansions (2017-2019)
Table 146 Approvals (2017-2019)
Table 147 Acquisitions (2017-2019)
Table 148 Agreements And Collaboration (2017-2019)
Table 149 Others (2017-2019)
Table 150 Aurobindo Pharma Limited: Total Revenue And R&D Expenses (2015-2017) ($Mn)
Table 151 Aurobindo Pharma Limited: Total Revenue, By Segment (2015-2017) ($Mn)
Table 152 Aurobindo Pharma Limited: Total Revenue, By Geography (2015-2017) ($Mn)
Table 153 Boehringer Ingelheim Gmbh: Total Revenue And R&D Expenses (2015-2017) ($Mn)
Table 154 Boehringer Ingelheim Gmbh Total Revenue, By Segments (2015-2017) ($Mn)
Table 155 Boehringer Ingelheim Gmbh Total Revenue, By Geography (2015-2017) ($Mn)
Table 156 Cambrex: Total Revenue And R&D Expenses, (2016-2018) ($Mn)
Table 157 Cambrex: Total Revenue, By Segment, (2016-2018) ($Mn)
Table 158 Cambrex: Total Revenue, By Geography, (2016-2018) ($Mn)
Table 159 Divis Laboratories Ltd: Total Revenue And R&D Expenses (2016-2018) ($Mn)
Table 160 Divis Laboratories Ltd: Total Revenue, By Geography (2016-2018) ($Mn)
Table 161 Gsk: Total Revenue And R&D Expenses, (2016-2018) ($Mn)
Table 162 Gsk: Total Revenue, By Segment, (2016-2018) ($Mn)
Table 163 Gsk: Total Revenue, By Geography, (2016-2018) ($Mn)
Table 164 Lonza Group: Total Revenue And R&D Expenses, (2016-2018) ($Mn)
Table 165 Lonza Group: Total Revenue, By Segment, (2016-2018) ($Mn)
Table 166 Lonza Group: Total Revenue, By Geography, (2016-2018) ($Mn)
Table 167 Thermo Fisher Scientific: Total Revenue And R&D Expenses, (2016-2018) ($Mn)
Table 168 Thermo Fisher Scientific: Total Revenue, By Segment,(2016-2018) ($Mn)
Table 169 Thermo Fisher Scientific: Total Revenue, By Geography, (2016-2018) ($Mn)
Table 170 Pfizer Inc: Total Revenue And R&D Expenses, (2016-2018) ($Mn)
Table 171 Pfizer Inc: Total Revenue, By Segments, (2016-2018) ($Mn)
Table 172 Pfizer Inc: Total Revenue, By Geography, (2016-2018) ($Mn)
Table 173 Sanofi: Total Revenue And R&D Expenses (2016-2018) ($Mn)
Table 174 Sanofi: Total Revenue, By Segments (2016-2018) ($Mn)
Table 175 Sanofi: Total Revenue, By Geography (2016-2018) ($Mn)
Table 176 Siegfried Holdings Ag: Total Revenue And R&D Expenses (2016-2018) ($Mn)
Table 177 Siegfried Holdings Ag: Total Revenue, By Segments (2016-2018) ($Mn)
Table 178 Siegfried Holdings Ag: Total Revenue, By Geography (2016-2018) ($Mn)
Table 179 Teva Pharmaceutical Industries Limited: Total Revenue And R&D Expenses (2016-2018) ($Mn)
Table 180 Teva Pharmaceutical Industries Limited: Total Revenue, By Segments (2016-2018) ($Mn)
Table 181 Teva Pharmaceutical Industries Limited: Total Revenue, By Geography (2016-2018) ($Mn)

List of Figures
Figure 1 API Global Market Revenue, By Region (2017-2025) ($Mn)
Figure 2 Research Methodology: API Global Market
Figure 3 API Global Market: Top-Down And Bottom-Up Approach
Figure 4 API Global Market: Forecasting Model
Figure 5 API Global Market: Market Breakdown And Data Triangulation
Figure 6 API Global Market Segmentation
Figure 7 Market Dynamics
Figure 8 API Global Market: Porter’S Analysis
Figure 9 API Global Market: Supply Chain Analysis
Figure 10 Global API Market Share Analysis, 2018 (%)
Figure 11 Global API Manufacturing Landscape
Figure 12 Small Molecule API Production By Application (2018), In-House V/S CMO (2017 – 2025) (Tons) And Global Manufacturing CAPACities (2018) (Litres)
Figure 13 Global Total API And CMO Production (2017 – 2025) (Metric Tons)
Figure 14 Patent Expiry Of Small Molecules (2016-2021)
Figure 15 API Global Market Share, By Synthesis (2018 V/S 2025) (%)
Figure 16 API Global Market Share, By Region (2018 V/S 2025) (%)
Figure 17 Synthetic API Global Market Share, By Region (2018 V/S 2025) (%)
Figure 18 Synthetic API Global Market Share, By Customer Base (2018 V/S 2025) (%)
Figure 19 Biotech API Global Market Share, By Product Type, (2018 V/S 2025) (%)
Figure 20 Biotech API Global Market Share, By Region, (2018 V/S 2025) (%)
Figure 21 Biotech API Global Market Share, By Customer Base (2018 V/S 2025) (%)
Figure 22 HPAPI Global Market Share, By Region, (2018 V/S 2025) (%)
Figure 23 HPAPI Global Market Share, By Customer Base (2018 V/S 2025) (%)
Figure 24 API Global Market Share, By Business Type (2018 V/S 2025) (%)
Figure 25 Captive API Global Market Share, By Type (2018 V/S 2025) (%)
Figure 26 Captive API Global Market Share, By Region, (2018 V/S 2025) (%)
Figure 27 Merchant API Global Market Share, By Type (2018 V/S 2025) (%)
Figure 28 Merchant API Global Market Share, By Region, (2018 V/S 2025) (%)
Figure 29 API Global Market Share, By Application (2018 V/S 2025) (%)
Figure 30 Synthetic API Global Market Share, By Application (2018 V/S 2025) (%)
Figure 31 Biotech API Global Market Share, By Application (2018 V/S 2025) (%)
Figure 32 HPAPI Global Market Share, By Application (2018 V/S 2025) (%)
Figure 33 Cardiovascular Disorders API Global Market Share, By Region, (2018 V/S 2025) (%)
Figure 34 Pulmonary Disorders API Global Market Share, By Region, (2018 V/S 2025) (%)
Figure 35 Synthetic Pulmonary Disorders API Global Market Share, By Region, (2018 V/S 2025) (%)
Figure 36 Biotech Pulmonary Disorders API Global Market Share, By Region, (2018 V/S 2025) (%)
Figure 37 HPAPI Pulmonary Disorders API Global Market Share, By Region, (2018 V/S 2025) (%)
Figure 38 HPAPI Genitourinary Disorders API Global Market Share, By Region, (2018 V/S 2025) (%)
Figure 39 API Global Market Revenue, By Region (2017-2025) ($Mn), Cagr (%)
Figure 40 API Global Market Share, By Geography (2018) (%)
Figure 41 North America API Market Share, By Synthesis And Biotech API Market, By Type (2018 V/S 2025) (%)
Figure 42 North America Synthetic API, Biotech API And HPAPI Market Share, By Customer Base (2018 V/S 2025) (%)
Figure 43 North America API Market Share, By Business Type, Captive API And Merchant API Market, By Type (2018 V/S 2025) (%)
Figure 44 North America API Market Share, By Application (2018) (%), CAGR (%)
Figure 45 North America Synthetic API Market Share, By Application (2018) (%), CAGR (%)
Figure 46 North America Biotech API Market Share, By Application (2018) (%), CAGR (%)
Figure 47 North America HPAPI Market Share, By Application (2018) (%), CAGR (%)
Figure 48 North America API Share, By Country (2018 V/S 2025) (%)
Figure 49 U.S. API Market Revenue, By Synthesis Type, Biotech API Market Revenue, By Type And API Market, By Business Type (2018 V/S 2025) ($Mn)
Figure 50 U.S. API Market Revenue, By Application (2018) ($Mn), CAGR (%)
Figure 51 U.S. Synthetic API Market Revenue, By Application (2018) ($Mn), CAGR (%)
Figure 52 U.S. Biotech API Market Revenue, By Application (2018) ($Mn), CAGR (%)
Figure 53 U.S. HPAPI Market Revenue, By Application (2018) ($Mn), CAGR (%)
Figure 54 Rest Of N.A. API Market Revenue, By Business Type, Biotech API Market Revenue, By Type And API Market, By Business Type (2018 V/S 2025) ($Mn)
Figure 55 Rest Of N.A. API Market Revenue, By Application (2018) ($Mn), CAGR (%)
Figure 56 Rest Of N.A. Synthetic API Market Revenue, By Application (2018) ($Mn), CAGR (%)
Figure 57 Rest Of N.A. Biotech API Market Revenue, By Application (2018) ($Mn), CAGR (%)
Figure 58 Rest Of N.A. HPAPI Market Revenue, By Application (2018) ($Mn), CAGR (%)
Figure 59 Europe API Market Share, By Synthesis And Biotech API Market, By Type (2018 V/S 2025) (%)
Figure 60 Europe Synthetic API, Biotech API And HPAPI Market Share, By Customer Base (2018 V/S 2025) (%)
Figure 61 Europe API Market Share, By Business Type, Captive API And Merchant API Market, By Type (2018 V/S 2025) (%)
Figure 62 Europe API Market Share, By Application (2018) (%), CAGR (%)
Figure 63 Europe Synthetic API Market Share, By Application (2018) (%), CAGR (%)
Figure 64 Europe Biotech API Market Share, By Application (2018) (%), CAGR (%)
Figure 65 Europe HPAPI Market Share, By Application (2018) (%), CAGR (%)
Figure 66 Europe API Share, By Country (2018 V/S 2025) (%)
Figure 67 Italy API Market Revenue, By Business Type, Biotech API Market Revenue, By Type And API Market, By Business Type (2018 V/S 2025) ($Mn)
Figure 68 Italy API Market Revenue, By Application (2018) ($Mn), CAGR (%)
Figure 69 Italy Synthetic API Market Revenue, By Application (2018) ($Mn), CAGR (%)
Figure 70 Italy Biotech API Market Revenue, By Application (2018) ($Mn), CAGR (%)
Figure 71 Italy HPAPI Market Revenue, By Application (2018) ($Mn), CAGR (%)
Figure 72 Germany API Market Revenue, By Business Type, Biotech API Market Revenue, By Type And API Market, By Business Type (2018 V/S 2025) ($Mn)
Figure 73 Germany API Market Revenue, By Application (2018) ($Mn), CAGR (%)
Figure 74 Germany Synthetic API Market Revenue, By Application (2018) ($Mn), CAGR (%)
Figure 75 Germany Biotech API Market Revenue, By Application (2018) ($Mn), CAGR (%)
Figure 76 Germany HPAPI Market Revenue, By Application (2018) ($Mn), CAGR (%)
Figure 77 France API Market Revenue, By Business Type, Biotech API Market Revenue, By Type And API Market, By Business Type (2018 V/S 2025) ($Mn)
Figure 78 France API Market Revenue, By Application (2018) ($Mn), CAGR (%)
Figure 79 France Synthetic API Market Revenue, By Application (2018) ($Mn), CAGR (%)
Figure 80 France Biotech API Market Revenue, By Application (2018) ($Mn), CAGR (%)
Figure 81 France HPAPI Market Revenue, By Application (2018) ($Mn), CAGR (%)
Figure 82 Rest Of Europe API Market Revenue, By Business Type, Biotech API Market Revenue, By Type And API Market, By Business Type (2018 V/S 2025) ($Mn)
Figure 83 Rest Of Europe API Market Revenue, By Application (2018) ($Mn), CAGR (%)
Figure 84 Rest Of Europe Synthetic API Market Revenue, By Application (2018) ($Mn), CAGR (%)
Figure 85 Rest Of Europe Biotech API Market Revenue, By Application (2018) ($Mn), CAGR (%)
Figure 86 Rest Of Europe HPAPI Market Revenue, By Application (2018) ($Mn), CAGR (%)
Figure 87 APAC API Market Share, By Synthesis And Biotech API Market, By Type (2018 V/S 2025) (%)
Figure 88 APAC Synthetic API, Biotech API And HPAPI Market Share, By Customer Base (2018 V/S 2025) (%)
Figure 89 APAC API Market Share, By Business Type, Captive API And Merchant API Market, By Type (2018 V/S 2025) (%)
Figure 90 APAC API Market Share, By Application (2018) (%), CAGR (%)
Figure 91 APAC Synthetic API Market Share, By Application (2018) (%), CAGR (%)
Figure 92 APAC Biotech API Market Share, By Application (2018) (%), CAGR (%)
Figure 93 APAC HPAPI Market Share, By Application (2018) (%), CAGR (%)
Figure 94 Rest Of APAC API Share, By Country (2018 V/S 2025) (%)
Figure 95 China API Market Revenue, By Business Type, Biotech API Market Revenue, By Type And API Market, By Business Type (2018 V/S 2025) ($Mn)
Figure 96 China API Market Revenue, By Application (2018) ($Mn), CAGR (%)
Figure 97 China Synthetic API Market Revenue, By Application (2018) ($Mn), CAGR (%)
Figure 98 China Biotech API Market Revenue, By Application (2018) ($Mn), CAGR (%)
Figure 99 China HPAPI Market Revenue, By Application (2018) ($Mn), CAGR (%)
Figure 100 Japan API Market Revenue, By Business Type, Biotech API Market Revenue, By Type And API Market, By Business Type (2018 V/S 2025) ($Mn)
Figure 101 Japan API Market Revenue, By Application (2018) ($Mn), CAGR (%)
Figure 102 Japan Synthetic API Market Revenue, By Application (2018) ($Mn), CAGR (%)
Figure 103 Japan Biotech API Market Revenue, By Application (2018) ($Mn), CAGR (%)
Figure 104 Japan HPAPI Market Revenue, By Application (2018) ($Mn), CAGR (%)
Figure 105 India API Market Revenue, By Business Type, Biotech API Market Revenue, By Type And API Market, By Business Type (2018 V/S 2025) ($Mn)
Figure 106 India API Market Revenue, By Application (2018) ($Mn), CAGR (%)
Figure 107 India Synthetic API Market Revenue, By Application (2018) ($Mn), CAGR (%)
Figure 108 India Biotech API Market Revenue, By Application (2018) ($Mn), CAGR (%)
Figure 109 India HPAPI Market Revenue, By Application (2018) ($Mn), CAGR (%)
Figure 110 Rest Of APAC API Market Revenue, By Business Type, Biotech API Market Revenue, By Type And API Market, By Business Type (2018 V/S 2025) ($Mn)
Figure 111 Rest Of APAC API Market Revenue, By Application (2018) ($Mn), CAGR (%)
Figure 112 Rest Of APAC Synthetic API Market Revenue, By Application (2018) ($Mn), CAGR (%)
Figure 113 Rest Of APAC Biotech API Market Revenue, By Application (2018) ($Mn), CAGR (%)
Figure 114 Rest Of APAC HPAPI Market Revenue, By Application (2018) ($Mn), CAGR (%)
Figure 115 RoW API Market Share, By Synthesis And Biotech API Market, By Type (2018 V/S 2025) (%)
Figure 116 RoW Synthetic API, Biotech API And HPAPI Market Share, By Customer Base (2018 V/S 2025) (%)
Figure 117 RoW API Market Share, By Business Type, Captive API And Merchant API Market, By Type (2018 V/S 2025) (%)
Figure 118 RoW API Market Share, By Application (2018) (%), CAGR (%)
Figure 119 RoW Synthetic API Market Share, By Application (2018) (%), CAGR (%)
Figure 120 RoW Biotech API Market Share, By Application (2018) (%), CAGR (%)
Figure 121 RoW HPAPI Market Share, By Application (2018) (%), CAGR (%)
Figure 122 RoW API Share, By Country (2018 V/S 2025) (%)
Figure 123 Brazil API Market Revenue, By Business Type, Biotech API Market Revenue, By Type And API Market, By Business Type (2018 V/S 2025) ($Mn)
Figure 124 Brazil API Market Revenue, By Application (2018) ($Mn), CAGR (%)
Figure 125 Brazil Synthetic API Market Revenue, By Application (2018) ($Mn), CAGR (%)
Figure 126 Brazil Biotech API Market Revenue, By Application (2018) ($Mn), CAGR (%)
Figure 127 Brazil HPAPI Market Revenue, By Application (2018) ($Mn), CAGR (%)
Figure 128 Rest Of LATAM API Market Revenue, By Business Type, Biotech API Market Revenue, By Type And API Market, By Business Type (2018 V/S 2025) ($Mn)
Figure 129 Rest Of LATAM API Market Revenue, By Application (2018) ($Mn), CAGR (%)
Figure 130 Rest Of LATAM Synthetic API Market Revenue, By Application (2018) ($Mn), CAGR (%)
Figure 131 Rest Of LATAM Biotech API Market Revenue, By Application (2018) ($Mn), CAGR (%)
Figure 132 Rest Of LATAM HPAPI Market Revenue, By Application (2018) ($Mn), CAGR (%)
Figure 133 Middle East & Others API Market Revenue, By Business Type, Biotech API Market Revenue, By Type And API Market, By Business Type (2018 V/S 2025) ($Mn)
Figure 134 Middle East & Others API Market Revenue, By Application (2018) ($Mn), CAGR (%)
Figure 135 Middle East & Others Synthetic API Market Revenue, By Application (2018) ($Mn), CAGR (%)
Figure 136 Middle East & Others Biotech API Market Revenue, By Application (2018) ($Mn), CAGR (%)
Figure 137 Middle East & Others HPAPI Market Revenue, By Application (2018) ($Mn), CAGR (%)
Figure 138 Key Growth Strategies, (2017-2018)
Figure 139 SWOT: Amri
Figure 140 SWOT: Aurobindo Pharma Limited.
Figure 141 SWOT: Boehringer Ingelheim Gmbh
Figure 142 SWOT: Cambrex Corporation
Figure 143 SWOT: Divis Laboratories
Figure 144 SWOT: GlaxoSmithKline Plc
Figure 145 SWOT: Lonza Group
Figure 146 SWOT: Olon S.P.A
Figure 147 SWOT: Patheon N.V.
Figure 148 SWOT: Pfizer Inc.
Figure 149 SWOT: Sanofi
Figure 150 SWOT: Siegfried Holdings A.G.
Figure 151 SWOT: Teva Pharmaceutical Industries Ltd.

Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Aarti Drugs Ltd
  • Aash Biotech Pvt Ltd.
  • Abbvie
  • ABC International Pharma Srl.
  • ABClonal
  • J.H Whitney Capital Partners LLC (Accupac, Inc.)
  • Achaogen Inc.
  • Acic Pharmaceutical Inc.
  • Adimmune Corporation
  • Aesica Pharmaceuticals
  • AGc Group
  • AGc Biologics
  • Ajantha Pharma
  • Ajinomoto Bio-Pharma Services
  • Akorn
  • Albany Molecular Research Inc (AMRI)
  • Albemarle Corporation
  • Alcami Corporation
  • Alembic Ltd.
  • Alfachemicals
  • Alkem Laboratories Ltd.
  • Alkermes Plc
  • ALLChem
  • Allergan Plc
  • Almac Group
  • Almelo Private Limited
  • Alpic Remedies
  • Alven Laboratories
  • Ambio Pharma Inc.
  • Amega Biotech
  • Amgen
  • Amneal Pharmaceuticals LLC
  • Amoytop Biotech
  • Ampac Fine Chemicals
  • Angelini Acraf S.P.A.
  • Apicore Us LLC
  • Apotex Fermentation Inc
  • Aqvida GmbH
  • Arena Pharmaceuticals
  • Arene Lifesciences Limited
  • Arevipharma GmbH
  • Ariston Pharma Novatech Pvt., Ltd.
  • Aspire Lifesciences Pvt., Ltd.
  • Astrazeneca Plc.
  • Aurobindo Pharma Ltd.
  • Avra Laboratories Pvt., Ltd.
  • Azad Pharma AG
  • Bachem Holding AG
  • Bal Pharma Ltd.
  • Basf
  • Baxter International Inc.
  • Bayer Pharma Chemicals
  • Biocodex S.A.
  • Biocon Ltd.
  • Biogen
  • Biomax Pharma
  • Biomerin Pharmaceutical Inc.
  • Biophore India Pharmaceuticals Pvt., Ltd.
  • Biosortia Pharmaceuticals
  • Biotechnica Pharma Global
  • Biovian
  • Blanver Farmoquimica
  • Boehringer Ingelheim GmbH.
  • Brammer Bio
  • Brawn Laboratories Ltd.
  • Bristol-Myers Squibb
  • Cadila Pharmaceuticals Limited
  • Cambrex Corporation
  • Catalent
  • Cayman Chemicals
  • Celgene
  • Celltrion Inc.
  • Century Pharmaceuticals Ltd.
  • Cerbios-Pharma Sa
  • Cfm Group (Amsa S.P.A)
  • Changzhou Pharmaceutical Factory
  • Chemcon GmbH
  • China Chemical & Pharmaceutical Co., Ltd.
  • Chongqing Huapont Pharmaceutical Co., Ltd.
  • Cipla Limited
  • Ckd Bio
  • Coba Pharma
  • Corden Pharma
  • Crystalia
  • Csl Ltd
  • Ctx Lifesciences
  • Daiichi Sankyo Chemical Pharma Co Ltd.
  • Daito Pharmaceutical Co., Ltd.
  • Dalton Research Molecule
  • Dcs Pharma AG
  • Dishman Pharmaceuticals
  • Divis Laboratories
  • Dong Wha Pharm Ind Co Ltd.
  • Dr.Reddy's Laboratories
  • Eirgen Pharma
  • Eisai
  • Eli Lilly Pharmaceuticals
  • Emcure Pharmaceuticals Ltd.
  • Enaltec Labs Private Limited.
  • Ercros
  • Estechpharma Co., Ltd.
  • Esteve Química
  • Everest Organics Limited.
  • Evonik Industries AG
  • Fareva Group
  • Farmabios
  • Ferring Pharmaceuticals
  • Fis Fabbrica Italiana Sintetici S.P.A.
  • Flamma S.P.A.
  • Florentis Pharmaceuticals Pvt., Ltd.
  • Formosa Laboratories Inc.
  • Fuji Chemical Industry Co., Ltd.
  • GE Healthcare Bio-Sciences Ab
  • Gentec Pharmaceutical Group S.A
  • Gilead Sciences, Inc.
  • Gland Pharma Limited.
  • Glaxosmithkline Plc.
  • Glenmark Generics Ltd.
  • Gnosis S.P.A.
  • Granules India Ltd.
  • GVK Industries Limited (Gvk Bioscience)
  • Haoyuan Chemexpress Co.Ltd.
  • Harman Finochem Limited.
  • Heni Chemical Industries
  • Heraues Holding GmbH
  • Hetero Labs Ltd.
  • Hikma Pharmaceuticals
  • Honour Lab Ltd.
  • Hovione
  • Huvapharma
  • Hybio Pharmaceutical Co., Ltd.
  • Ibio Inc
  • Icrom S.P.A.
  • Inabata Pharmasynthese
  • Inalco Pharmaceuticals
  • Indena
  • Insight Biopharmaceutical
  • Intas Pharmaceuticals Ltd.
  • Interquim, S.A.
  • Jeil Pharmaceutical Co. Ltd.
  • Johnson And Johnson (Janssen Pharmaceutica Nv, Belgium)
  • Jubilant Lifesciences (Jubilant Generics Ltd.)
  • Katsura Chemical Co.,Ltd.
  • Kern Pharma, S.L.
  • Kleos Pharma
  • Kongo Yakuhin Co., Ltd.
  • Kosher Pharmaceuticals
  • Krka Pharmaceuticals
  • Kyowa Hakko Kirin
  • Ofichem BV
  • Lannett Co. Inc.
  • Laurus Labs.
  • Lebsa
  • Lgm Pharma.
  • Libbs
  • Liptis Pharmaceuticals
  • Lonza Group
  • Lotus Pharmaceutical Co., Ltd.
  • Lupin
  • Lusochimica S.P.A
  • Macleods Pharmaceutical Ltd.
  • MAGle Chemoswed Ab
  • Mallinckrodt Pharmaceuticals
  • Medichem S.A
  • Megafine Pharma Ltd
  • Mehta Api
  • Merck Group (Merck Kgaa)
  • Metrochem Api
  • Micro Labs Ltd.
  • Minakem S.A.
  • Moehs Iberica S.L.
  • Molcan Corporation
  • Morepen
  • Msn Organics Pvt, Ltd.
  • Mylan N.V
  • Nanomedex Pharmaceuticals
  • Natco Pharma Ltd.
  • Neovacs Kinoid
  • Neuland Laboratories Ltd.
  • Neuraxpharm Arzneimittel (Inke)
  • Nifty Labs Pvt Ltd.
  • Norchim
  • Novartis AG
  • Novasep
  • Novo Nordisk
  • Novocap,
  • Olainfarm Jsc.
  • Olon S.P.A.
  • Oncobiologics
  • Optimus Drugs Private Ltd.
  • Orchid Chemicals & Pharmaceuticals Ltd.
  • Orion (Fermion)
  • Paratek Pharmaceutical
  • Pcas
  • Pellets Pharma Limited
  • Perrigo
  • Pfizer
  • Pfanstiehl
  • Pharmispania
  • Phyton Biotech LLC
  • Pierre Fabre
  • Piramal Enterprises Ltd.
  • Polpharma Bb
  • Prajna Generics Pvt. Ltd.
  • Precise Group
  • Probiogen AG
  • Princeton Biomolecular Research, Inc.
  • Rablon Healthcare Pvt Ltd.
  • Raks Pharma Pvt Ltd.
  • Recipharm Ab
  • Regeneron
  • Reine Lifescience
  • Reliance Life Sciences Pvt., Ltd.
  • Reva Pharma Pvt., Ltd.
  • Roche
  • Rochem International Inc.
  • Rpg Life Sciences
  • Rxn Chemicals Pvt. Ltd.
  • Saamya Biotech
  • Sajjala Bio Labs
  • Sandoz International GmbH
  • Saneca Pharmaceuticals
  • Sanofi S.A.
  • Scinopharm Taiwan Ltd.
  • Servier
  • Shenzhen Haorui Industrial Dev.
  • Shilpa Medicare Limited
  • Shiono Chemical Co., Ltd.
  • Shire Pharmaceuticals
  • Shouyuan Chemical
  • Shreeji Pharma International
  • Siegfried Holdinngs AG
  • Sigma-Aldrich
  • Sigmapharm Laboratories LLC.
  • SM Biomed Sdn. Bhd
  • Smilax Laboratories Limited
  • Sms Pharmaceuticals Limited
  • Solara A Pharma Sciences Ltd.
  • Srini Pharmaceuticals Ltd.
  • Standard Chemical & Pharmaceutical Co.
  • Sterling Biotech Ltd.
  • Strides Shasun Limited
  • Sumitomo Dainippon Pharma Co., Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Suven Life Science Ltd.
  • Suzhou Ryway Biotech
  • Symbiotec Pharma Lab Pvt., Ltd
  • Synergene Active Ingredients Pvt, Ltd.
  • Syn-Tech Chem. And Pharma.Co., Ltd.
  • Takeda Pharmaceutical Company Ltd.
  • Taro Pharmaceutical Industries Ltd.
  • Temad Co.
  • Tetraphase Pharmaceuticals
  • Teva Pharmaceuticals Industries Ltd.
  • Therapeutic Md Inc.
  • Theravance Biopharma
  • Thermo Fisher Scientific Corporation
  • Torrent Pharmaceuticals, Ltd.
  • Trifecta Pharmaceuticals LLC
  • Trimax Bio Sciences (P) Limited
  • Umicore
  • Unichem Laboratories Ltd.
  • Union Quimico Farmaceutica, S.A.
  • Unique Biotech Ltd.
  • USV Ltd.
  • Vaishali Pharma Ltd.
  • Venus Remedies (Venus Pharma GmbH)
  • Vertex Pharmeceuticals
  • Viruj Pharma
  • Vivimed Labs Ltd.
  • Wanbury Ltd.
  • Watson Pharma Private Ltd.
  • Wavelength Pharmaceuticals
  • Wellona Pharmaceuticals
  • Welt Care Lifesciences Pvt., Ltd.
  • Wockhardt Limited
  • Wuxi Apptec (Sta Pharmaceutical Co., Ltd.)
  • Xellia Pharmaceuticals
  • Yabao Pharmaceutical Group Co., Ltd.
  • Yangtze River Pharmaceutical Group
  • Yung Zip Chemical Industrial Co., Ltd.
  • Zambon Group (Zach)
  • ZCL Chemicals Ltd.
  • Zhejiang Hisun Pharmaceutical Co., Ltd.
  • Zhejiang Huahai Pharmaceutical Co., Ltd.
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4769388
Adroll
adroll